Browsing: offers
Imlunestrant, an investigational next-generation selective estrogen receptor antagonist (SERD), improved progression-free survival in patients with advanced endocrine therapy, ER-positive, HER2-negative…
This year, get family and friends holiday gifts that say: I see you, I understand you, I love you! Apex…
The first ‘blueprint’ of human skeletal development reveals how the skeleton is formed, shedding light on the arthritis process and…
In a major advance against the growing threat of antibiotic-resistant bacteria, researchers have identified a new class of antimicrobial agents…
KRAS is the most mutated gene in cancer with mutations occurring in 17%-25% of all cancers, affecting millions of patients…
A new drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new…
Researcher Samantha Boch has studied the impact of incarceration on child and family health for more than a decade. Her…
A breakthrough for biomedical research promises new insights into immunotherapy development and disease modeling. Scientists at the University of Texas…
Nearly 3% of all children in the United States are diagnosed with autism, according to the Centers for Disease Control…
In a 10-center study, microwave ablation offered progression-free survival rates and fewer complications than surgery in treating a form of…